APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isoflurane Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Isoflurane Anesthesia Drugs Industry Growth and Trends Forecast to 2032

27 December 2025105 pages

Choose your research edition.

Industry ResearchIsoflurane Anesthesia Drugs Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Isoflurane Anesthesia Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Isoflurane Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isoflurane Anesthesia Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Isoflurane Anesthesia Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Isoflurane Anesthesia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Isoflurane Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Isoflurane Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isoflurane Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Isoflurane Anesthesia Drugs include KALBE PHARMA, Lunan Beite, Viatris, Baxter, Sedana Medical, PT Novell Pharmaceutical, Piramal, Neon Laboratories and LAB UNKNOWN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Isoflurane Anesthesia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Isoflurane Anesthesia Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Isoflurane Anesthesia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Isoflurane Anesthesia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Isoflurane Anesthesia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Isoflurane Anesthesia Drugs Market by Company

KALBE PHARMA

Lunan Beite

Viatris

Baxter

Sedana Medical

PT Novell Pharmaceutical

Piramal

Neon Laboratories

LAB UNKNOWN

AbbVie

Isoflurane Anesthesia Drugs Segment by Type

Brand Drug

Generic Drugs

Isoflurane Anesthesia Drugs Segment by Application

Hospital

Clinic

Other

Isoflurane Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoflurane Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoflurane Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoflurane Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Isoflurane Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Isoflurane Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Brand Drug Table 2. Major Company of Generic Drugs Table 3. Global Isoflurane Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Isoflurane Anesthesia Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Isoflurane Anesthesia Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Isoflurane Anesthesia Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Isoflurane Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Isoflurane Anesthesia Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Isoflurane Anesthesia Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Isoflurane Anesthesia Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Isoflurane Anesthesia Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Isoflurane Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Isoflurane Anesthesia Drugs Industry Trends Table 25. Isoflurane Anesthesia Drugs Industry Drivers Table 26. Isoflurane Anesthesia Drugs Industry Opportunities and Challenges Table 27. Isoflurane Anesthesia Drugs Industry Restraints Table 28. Global Isoflurane Anesthesia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Isoflurane Anesthesia Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Isoflurane Anesthesia Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Isoflurane Anesthesia Drugs Sales Share by Company (2021-2026) Table 32. Global Isoflurane Anesthesia Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Isoflurane Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Isoflurane Anesthesia Drugs Major Company Production Sites and Headquarters Table 35. Global Isoflurane Anesthesia Drugs Company, Product Type & Application Table 36. Global Isoflurane Anesthesia Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Isoflurane Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Isoflurane Anesthesia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Isoflurane Anesthesia Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Isoflurane Anesthesia Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Isoflurane Anesthesia Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Isoflurane Anesthesia Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Isoflurane Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Isoflurane Anesthesia Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Isoflurane Anesthesia Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Isoflurane Anesthesia Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Isoflurane Anesthesia Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Isoflurane Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Isoflurane Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Isoflurane Anesthesia Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Isoflurane Anesthesia Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Isoflurane Anesthesia Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Isoflurane Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Isoflurane Anesthesia Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Isoflurane Anesthesia Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Isoflurane Anesthesia Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Isoflurane Anesthesia Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Isoflurane Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. KALBE PHARMA Company Information Table 72. KALBE PHARMA Business Overview Table 73. KALBE PHARMA Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. KALBE PHARMA Isoflurane Anesthesia Drugs Product Portfolio Table 75. KALBE PHARMA Recent Development Table 76. Lunan Beite Company Information Table 77. Lunan Beite Business Overview Table 78. Lunan Beite Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Lunan Beite Isoflurane Anesthesia Drugs Product Portfolio Table 80. Lunan Beite Recent Development Table 81. Viatris Company Information Table 82. Viatris Business Overview Table 83. Viatris Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Viatris Isoflurane Anesthesia Drugs Product Portfolio Table 85. Viatris Recent Development Table 86. Baxter Company Information Table 87. Baxter Business Overview Table 88. Baxter Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Baxter Isoflurane Anesthesia Drugs Product Portfolio Table 90. Baxter Recent Development Table 91. Sedana Medical Company Information Table 92. Sedana Medical Business Overview Table 93. Sedana Medical Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sedana Medical Isoflurane Anesthesia Drugs Product Portfolio Table 95. Sedana Medical Recent Development Table 96. PT Novell Pharmaceutical Company Information Table 97. PT Novell Pharmaceutical Business Overview Table 98. PT Novell Pharmaceutical Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. PT Novell Pharmaceutical Isoflurane Anesthesia Drugs Product Portfolio Table 100. PT Novell Pharmaceutical Recent Development Table 101. Piramal Company Information Table 102. Piramal Business Overview Table 103. Piramal Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Piramal Isoflurane Anesthesia Drugs Product Portfolio Table 105. Piramal Recent Development Table 106. Neon Laboratories Company Information Table 107. Neon Laboratories Business Overview Table 108. Neon Laboratories Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Neon Laboratories Isoflurane Anesthesia Drugs Product Portfolio Table 110. Neon Laboratories Recent Development Table 111. LAB UNKNOWN Company Information Table 112. LAB UNKNOWN Business Overview Table 113. LAB UNKNOWN Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. LAB UNKNOWN Isoflurane Anesthesia Drugs Product Portfolio Table 115. LAB UNKNOWN Recent Development Table 116. AbbVie Company Information Table 117. AbbVie Business Overview Table 118. AbbVie Isoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. AbbVie Isoflurane Anesthesia Drugs Product Portfolio Table 120. AbbVie Recent Development Table 121. North America Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Isoflurane Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 123. North America Isoflurane Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 124. North America Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Isoflurane Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Isoflurane Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Isoflurane Anesthesia Drugs Market Share by Country (2021-2026) Table 129. North America Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Isoflurane Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Isoflurane Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 133. Europe Isoflurane Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Isoflurane Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Isoflurane Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Isoflurane Anesthesia Drugs Market Share by Country (2021-2026) Table 139. Europe Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Isoflurane Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Isoflurane Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Isoflurane Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Isoflurane Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Isoflurane Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Isoflurane Anesthesia Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Isoflurane Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Isoflurane Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 153. Latin America Isoflurane Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Isoflurane Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Isoflurane Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Isoflurane Anesthesia Drugs Market Share by Country (2021-2026) Table 159. Latin America Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Isoflurane Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Isoflurane Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Isoflurane Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Isoflurane Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Isoflurane Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Isoflurane Anesthesia Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Isoflurane Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Isoflurane Anesthesia Drugs Distributors List Table 174. Isoflurane Anesthesia Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Isoflurane Anesthesia Drugs Image Figure 2. Global Isoflurane Anesthesia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoflurane Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Isoflurane Anesthesia Drugs Sales (2021-2032) & (K Units) Figure 5. Brand Drug Image Figure 6. Global Brand Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drugs Image Figure 8. Global Generic Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Isoflurane Anesthesia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Isoflurane Anesthesia Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Isoflurane Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Isoflurane Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Isoflurane Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Isoflurane Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Isoflurane Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Isoflurane Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Isoflurane Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Isoflurane Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Isoflurane Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Isoflurane Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Isoflurane Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Isoflurane Anesthesia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Isoflurane Anesthesia Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Isoflurane Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Isoflurane Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Isoflurane Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Isoflurane Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Isoflurane Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Isoflurane Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Isoflurane Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Isoflurane Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Isoflurane Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Isoflurane Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Isoflurane Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Isoflurane Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Isoflurane Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Isoflurane Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Isoflurane Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Isoflurane Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Isoflurane Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Isoflurane Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Isoflurane Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Isoflurane Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Isoflurane Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Isoflurane Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Isoflurane Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Isoflurane Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Isoflurane Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Isoflurane Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Isoflurane Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Isoflurane Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Isoflurane Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Isoflurane Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Isoflurane Anesthesia Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Isoflurane Anesthesia Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • KALBE PHARMA
  • Lunan Beite
  • Viatris
  • Baxter
  • Sedana Medical
  • PT Novell Pharmaceutical
  • Piramal
  • Neon Laboratories
  • LAB UNKNOWN
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Isoflurane Anesthesia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Isoflurane Anesthesia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Isoflurane Anesthesia Drugs Market by Type
  6. 1.3.1 Brand Drug
  7. 1.3.2 Generic Drugs
  8. 1.4 Global Isoflurane Anesthesia Drugs Market Size by Type
  9. 1.4.1 Global Isoflurane Anesthesia Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Isoflurane Anesthesia Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Isoflurane Anesthesia Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Isoflurane Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Isoflurane Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Isoflurane Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Isoflurane Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Isoflurane Anesthesia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Isoflurane Anesthesia Drugs Industry Trends
  2. 2.2 Isoflurane Anesthesia Drugs Industry Drivers
  3. 2.3 Isoflurane Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Isoflurane Anesthesia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Isoflurane Anesthesia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Isoflurane Anesthesia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Isoflurane Anesthesia Drugs Price (2021-2026)
  4. 3.4 Global Isoflurane Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Isoflurane Anesthesia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Isoflurane Anesthesia Drugs Company, Product Type & Application
  7. 3.7 Global Isoflurane Anesthesia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Isoflurane Anesthesia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Isoflurane Anesthesia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Isoflurane Anesthesia Drugs Tier 1, Tier 2, and Tier 3
4 Isoflurane Anesthesia Drugs Regional Status and Outlook
  1. 4.1 Global Isoflurane Anesthesia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Isoflurane Anesthesia Drugs Historic Market Size by Region
  3. 4.2.1 Global Isoflurane Anesthesia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Isoflurane Anesthesia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Isoflurane Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Isoflurane Anesthesia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Isoflurane Anesthesia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Isoflurane Anesthesia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Isoflurane Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Isoflurane Anesthesia Drugs by Application
  1. 5.1 Isoflurane Anesthesia Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Isoflurane Anesthesia Drugs Market Size by Application
  6. 5.2.1 Global Isoflurane Anesthesia Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Isoflurane Anesthesia Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Isoflurane Anesthesia Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Isoflurane Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Isoflurane Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Isoflurane Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Isoflurane Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Isoflurane Anesthesia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 KALBE PHARMA
  2. 6.1.1 KALBE PHARMA Company Information
  3. 6.1.2 KALBE PHARMA Business Overview
  4. 6.1.3 KALBE PHARMA Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 KALBE PHARMA Isoflurane Anesthesia Drugs Product Portfolio
  6. 6.1.5 KALBE PHARMA Recent Developments
  7. 6.2 Lunan Beite
  8. 6.2.1 Lunan Beite Company Information
  9. 6.2.2 Lunan Beite Business Overview
  10. 6.2.3 Lunan Beite Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lunan Beite Isoflurane Anesthesia Drugs Product Portfolio
  12. 6.2.5 Lunan Beite Recent Developments
  13. 6.3 Viatris
  14. 6.3.1 Viatris Company Information
  15. 6.3.2 Viatris Business Overview
  16. 6.3.3 Viatris Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Viatris Isoflurane Anesthesia Drugs Product Portfolio
  18. 6.3.5 Viatris Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Isoflurane Anesthesia Drugs Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Sedana Medical
  26. 6.5.1 Sedana Medical Company Information
  27. 6.5.2 Sedana Medical Business Overview
  28. 6.5.3 Sedana Medical Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sedana Medical Isoflurane Anesthesia Drugs Product Portfolio
  30. 6.5.5 Sedana Medical Recent Developments
  31. 6.6 PT Novell Pharmaceutical
  32. 6.6.1 PT Novell Pharmaceutical Company Information
  33. 6.6.2 PT Novell Pharmaceutical Business Overview
  34. 6.6.3 PT Novell Pharmaceutical Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PT Novell Pharmaceutical Isoflurane Anesthesia Drugs Product Portfolio
  36. 6.6.5 PT Novell Pharmaceutical Recent Developments
  37. 6.7 Piramal
  38. 6.7.1 Piramal Company Information
  39. 6.7.2 Piramal Business Overview
  40. 6.7.3 Piramal Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Piramal Isoflurane Anesthesia Drugs Product Portfolio
  42. 6.7.5 Piramal Recent Developments
  43. 6.8 Neon Laboratories
  44. 6.8.1 Neon Laboratories Company Information
  45. 6.8.2 Neon Laboratories Business Overview
  46. 6.8.3 Neon Laboratories Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Neon Laboratories Isoflurane Anesthesia Drugs Product Portfolio
  48. 6.8.5 Neon Laboratories Recent Developments
  49. 6.9 LAB UNKNOWN
  50. 6.9.1 LAB UNKNOWN Company Information
  51. 6.9.2 LAB UNKNOWN Business Overview
  52. 6.9.3 LAB UNKNOWN Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 LAB UNKNOWN Isoflurane Anesthesia Drugs Product Portfolio
  54. 6.9.5 LAB UNKNOWN Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Isoflurane Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Isoflurane Anesthesia Drugs Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
7 North America by Country
  1. 7.1 North America Isoflurane Anesthesia Drugs Sales by Country
  2. 7.1.1 North America Isoflurane Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Isoflurane Anesthesia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Isoflurane Anesthesia Drugs Market Size by Country
  6. 7.2.1 North America Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Isoflurane Anesthesia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Isoflurane Anesthesia Drugs Sales by Country
  2. 8.1.1 Europe Isoflurane Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Isoflurane Anesthesia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Isoflurane Anesthesia Drugs Market Size by Country
  6. 8.2.1 Europe Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Isoflurane Anesthesia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Isoflurane Anesthesia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Isoflurane Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Isoflurane Anesthesia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Isoflurane Anesthesia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Isoflurane Anesthesia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Isoflurane Anesthesia Drugs Sales by Country
  2. 10.1.1 South America Isoflurane Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Isoflurane Anesthesia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Isoflurane Anesthesia Drugs Market Size by Country
  6. 10.2.1 South America Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Isoflurane Anesthesia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Isoflurane Anesthesia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Isoflurane Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Isoflurane Anesthesia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Isoflurane Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Isoflurane Anesthesia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Isoflurane Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Isoflurane Anesthesia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Isoflurane Anesthesia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Isoflurane Anesthesia Drugs Value Chain Analysis
  2. 12.1.1 Isoflurane Anesthesia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Isoflurane Anesthesia Drugs Production Mode & Process
  7. 12.2 Isoflurane Anesthesia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Isoflurane Anesthesia Drugs Distributors
  10. 12.2.3 Isoflurane Anesthesia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst